Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VTRSthis companyViatris Inc.	$20.35	-4.15×	0.99×	1.02×	-70.63×	6.4%	35.1%	-18.6%	-24.6%	-23.9%	-7.9%	13.3%	1×	-33.77×	-5.65×	1.3×	3.9%	7	1.15	2	C
AMPHAmphastar Pharmaceuticals, Inc.	$28.74	12.75×	1.59×	1.74×	8.18×	241.3%	49.5%	19.5%	13.6%	12.4%	7.5%	9.7%	0.83×	2.29×	5.51×	4.02×	0.0%	6	2.19	4	A-
AMRXAmneal Pharmaceuticals, Inc.	$21.13	54.78×	-55.77×	1.31×	10.56×	-33.0%	37.6%	14.0%	2.4%	-101.8%	13.8%	6.8%	-38.65×	4.02×	1.75×	2.17×	0.0%	7	2.58	3	B
ANIPANI Pharmaceuticals, Inc.	$67.63	22.55×	2.93×	1.79×	7.83×	1187.9%	51.0%	9.2%	8.9%	14.5%	5.6%	9.5%	0.6×	0.19×	4.05×	2.71×	0.1%	7	2.58	3	B
OGNOrganon & Co.	$13.87	9.96×	2.47×	0.3×	7.82×	121.6%	54.1%	20.7%	3.0%	24.9%	5.4%	28.9%	11.7×	6.38×	2.55×	1.82×	4.7%	7	1.27	3	B
Peer median	—	17.65×	2.03×	1.52×	8.01×	181.4%	50.2%	16.8%	5.9%	13.5%	6.6%	9.6%	0.72×	3.15×	3.3×	2.44×	0.0%	7	2.38	3	—